We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+4.81%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$6.76B
AUM Growth
-$242M
Cap. Flow
-$327M
Cap. Flow %
-4.84%
Top 10 Hldgs %
33.67%
Holding
152
New
46
Increased
32
Reduced
19
Closed
46

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$211M
2
MCD icon
McDonald's
MCD
+$204M
3
PSFE icon
Paysafe
PSFE
+$175M
4
MA icon
Mastercard
MA
+$166M
5
RH icon
RH
RH
+$154M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$237M
2
NFLX icon
Netflix
NFLX
+$208M
3
CHTR icon
Charter Communications
CHTR
+$190M
4
ATVI
Activision Blizzard
ATVI
+$184M
5
FISV
Fiserv Inc
FISV
+$182M

Sector Composition

Rank Sector Weight
1 Healthcare 23.59%
2 Consumer Discretionary 21.28%
3 Technology 20%
4 Industrials 14.28%
5 Communication Services 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRNS
51
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$28.3M 0.42%
1,826,445
+396,273
+28% +$5.73M
BGRY
52
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$25.4M 0.37%
+2,500,000
New +$27M
TERN
53
DELISTED
Terns Pharmaceuticals
TERN
$24.8M 0.37%
+1,125,136
New +$24.7M
KALV
54
DELISTED
KalVista Pharmaceuticals
KALV
$24.7M 0.36%
959,892
+650,992
+211% +$17.1M
SANA icon
55
Sana Biotechnology
SANA
$980M
$22.3M 0.33%
+667,500
New +$21.7M
CZOO
56
DELISTED
Cazoo Group Ltd
CZOO
$22.2M 0.33%
+1,083
New +$25.2M
MREO
57
Mereo BioPharma
MREO
$47.3M
$21.5M 0.32%
6,365,500
+3,616,501
+132% +$12.8M
KURA icon
58
Kura Oncology
KURA
$850M
$20.7M 0.31%
732,415
+460,915
+170% +$14.6M
FBRX icon
59
Forte Biosciences
FBRX
$1.57B
$20.6M 0.3%
24,000
+11,000
+85% +$9.01M
LYFT icon
60
Lyft
LYFT
$6.63B
$19M 0.28%
300,000
-759,660
-72% -$42.4M
FULC icon
61
Fulcrum Therapeutics
FULC
$297M
$18M 0.27%
+1,525,885
New +$18.9M
IRON icon
62
Disc Medicine
IRON
$2.97B
$17.8M 0.26%
+43,745
New +$19.5M
TTWO icon
63
Take-Two Interactive
TTWO
$46.1B
$15.4M 0.23%
87,010
-268,413
-76% -$50.9M
DCPH
64
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$15.1M 0.22%
+336,808
New +$15.7M
MILE
65
DELISTED
Metromile, Inc. Common Stock
MILE
$14.4M 0.21%
1,400,010
+250,490
+22% +$3.82M
SIOX
66
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$14.3M 0.21%
+5,489,000
New +$15.5M
BOLT icon
67
Bolt Biotherapeutics
BOLT
$7.78M
$13.8M 0.2%
+21,018
New +$13.7M
IFRX icon
68
InflaRx
IFRX
$271M
$12.8M 0.19%
+3,285,000
New +$16.8M
EYPT icon
69
EyePoint Inc
EYPT
$1.2B
$12M 0.18%
+1,181,200
New +$13.3M
PNT
70
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$11.3M 0.17%
+1,076,000
New +$14.6M
NEXI
71
DELISTED
NexImmune, Inc. Common Stock
NEXI
$11.1M 0.16%
+23,171
New +$12.6M
FSRXU
72
DELISTED
FinServ Acquisition Corp. II Unit
FSRXU
$10.9M 0.16%
+1,092,600
New +$11.3M
SYRE icon
73
Spyre Therapeutics
SYRE
$9.25B
$10.8M 0.16%
54,683
+24,333
+80% +$4.67M
RXDX
74
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$10.6M 0.16%
+578,534
New +$11.9M
ALUS
75
DELISTED
Alussa Energy Acquisition Corp
ALUS
$10M 0.15%
+1,000,000
New +$11.2M
1 2
3
4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Suvretta Capital Management held 152 positions worth $6.76B, down 3.5% from $7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Suvretta Capital Management withdrew a net $327M in Q1 2021, closing 46 positions and reducing 19 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $237M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Suvretta Capital Management opened a new position in Walt Disney worth $212M.

  • Suvretta Capital Management's largest Q1 2021 buy was Walt Disney: 1,146,508 shares worth $212M.
  • Suvretta Capital Management added most to Uber in Q1 2021, an estimated $87.4M increase.
  • Suvretta Capital Management's biggest Q1 2021 reduction was Adobe, cutting an estimated $158M.
  • Suvretta Capital Management fully exited Meta Platforms (Facebook) in Q1 2021, selling an estimated $237M.
  • Suvretta Capital Management's ten largest holdings make up 34% of its $6.76B portfolio in Q1 2021.
  • Suvretta Capital Management opened 46 new positions and closed 46 in Q1 2021.
  • Suvretta Capital Management's portfolio value fell 3.5% quarter-over-quarter to $6.76B.

Based on Suvretta Capital Management's 13F filing for Q1 2021, filed 17 May 2021.